心脏毒性
药理学
氧化应激
医学
阿霉素
蒽环类
癌症
抗氧化剂
细胞凋亡
心肌保护
体内
促炎细胞因子
癌细胞
评论文章
临床试验
癌症治疗
化疗
生物信息学
癌症治疗
程序性细胞死亡
作者
Susanna М. Badalyan,Sylvie Rapior,Anush Barkhudaryan
摘要
Introduction: Cardiotoxicity is an undesirable side effect of chemotherapy that limits the effectiveness of cancer treatment. Almost all cardiotoxic agents cause cardiovascular complications, leading to oxidative stress and other pathological conditions. The search for bioactive compounds that mitigate chemotherapy‐induced cardiotoxicity is a priority in integrative cardiooncology. Content: The administration of anthracycline derivatives, particularly Doxorubicin (DOX) and Adriamycin, is limited due to the risk of development of heart failure. These drugs promote apoptosis and oxidative stress, decrease the activity of antioxidant enzymes, and increase the production of proinflammatory cytokines. The combination of DOX and natural cardioprotective agents has been shown to be an effective therapeutic strategy for improving the outcomes of cancer treatment. Mushrooms, as producers of pharmacologically active compounds with significant cardioprotective effects, have been shown to prevent DOX‐induced cardiotoxicity in in vivo models, restoring cell viability, reducing oxidative stress via mitochondria‐dependent apoptotic pathways, and improving myocardial function. Therefore, mushroom‐derived products may be effective against chemotherapy‐induced cardiotoxicity. This review discusses progress in integrative cardiooncology aimed at elucidating the cardioprotective potential of mushrooms as a preventive strategy against cardiotoxicity associated with antitumor treatment. Outlook: Further preclinical and clinical studies are needed to elucidate the antioxidant and antiinflammatory potential of mushrooms and their use as dietary supplements, given the synergistic effects of all bioactive molecules, supporting the prospect of developing clinically effective anticancer and cardioprotective agents.
科研通智能强力驱动
Strongly Powered by AbleSci AI